Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Wucherpfennig K < Wudhikarn K < Wueest S

Kitsada Wudhikarn
Unit of Translational Hematology, Division of Hematology and Research, Department of Medicine, Chulalongkorn University, Bangkok, Thailand;
Thaïlande
Unit of Translational Hematology, Division of Hematology and Research, Department of Medicine, Chulalongkorn University, Bangkok
Bangkok
000484
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY;
États-Unis
État de New York
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York
000484

<g>
<k>Wudhikarn K</k>
<l>
<g>
<k>Kitsada Wudhikarn</k>
<l>
<g>
<k>
<affiliation wicri:level="1">
<nlm:aff id="aff8">Unit of Translational Hematology, Division of Hematology and Research, Department of Medicine, Chulalongkorn University, Bangkok, Thailand;</nlm:aff>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Unit of Translational Hematology, Division of Hematology and Research, Department of Medicine, Chulalongkorn University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</k>
<l>
<i>000484</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="aff7">Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</k>
<l>
<i>000484</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021